If you’ve been feeding your baby Nara Organics infant formula, stop now. Nara Organics has issued a voluntary recall of all lots of its Powdered Infant Formula currently on the market, citing the potential risk of Clostridium botulinum contamination. The recall comes after the FDA and CDC notified the company that three infants who consumed Nara formula were hospitalized with infant botulism.
The three infants — located in California, Washington, and Pennsylvania — were treated with BabyBIG (Botulism Immune Globulin Intravenous). No deaths have been reported. Nara says its formula has not tested positive for C. botulinum, but is proceeding with the full recall out of caution while working with federal and state health authorities to investigate.
What is infant botulism?
Infant botulism is rare but serious. It occurs when a baby ingests Clostridium botulinum spores, which then colonize the intestinal tract and produce neurotoxins. Because infant guts are still developing, they’re uniquely vulnerable to this kind of colonization — unlike older children and adults, who can typically pass the spores without illness.
Signs and symptoms to watch for include:
Explore all articles: Pregnancy and birth guide
- Constipation
- Poor feeding
- Drooping eyelid (ptosis)
- Sluggish or unresponsive pupils
- Low muscle tone
- Difficulty sucking or swallowing
- Weak or changed cry
- Generalized weakness
- Difficulty breathing or, in severe cases, respiratory arrest
If your baby has consumed Nara formula and is showing any of these symptoms, contact your healthcare provider immediately.
Which products are affected?
The recall covers all lots of both Nara Organics Powdered Infant Formula varieties sold at Target stores, Target.com, and Nara.com between July 2025 and June 2026:
- Nara Organics Whole Milk Infant Formula, 700g — UPC 860013251901
- Nara Organics Whole Milk Infant Formula, 400g — UPC 860013251918
Check the bottom of each can for the lot code. The following lots are included in the recall:
- 408125075E14F2
- 708125076E14F2
- 708125083E14F2
- 408125139E14F2
- 708125141E14F2
- 708125145E14F2
- 708125174E14F2
- 709125273E14F2
- 709125280E14F2
- 709125288E14F2
- 409125307E14F2
- 70926019ENNB
- 70926029ENNB
- 70926035ENNB
- 70926039ENNB
- 70926042ENNB
The three specific lot codes linked to the hospitalized infants are: 709125280E14F2, 709125288E14F2, and 708125174E14F2.
What should parents do right now?
Stop using the product immediately, even if the formula appears and smells normal. Do not give it to your baby.
For refunds:
- Nara.com purchases from May or June 2026: Nara will automatically issue a refund.
- Other purchases (including from Target): Take a photo of the lot code on the bottom of the can and submit a refund request at nara.com/pages/refund-request-form.
- Target purchases: You can also return the product directly to any Target store or follow Target’s online return process.
Questions? Contact Nara at hello@nara.com or visit their website for updates.
How to report an illness or adverse event
If your baby has been affected, you can report it to the FDA through any of the following:
- Report a Product Problem through FDA SmartHub
- Complete an electronic Voluntary MedWatch form online at FDA.gov
- Complete a paper Voluntary MedWatch form and mail it to the FDA
What we know about the investigation
The FDA and CDC contacted Nara Organics on Friday, June 12, 2026, informing the company of the three botulism cases. The investigation into the root cause is ongoing. Nara says its formula has not tested positive for C. botulinum as of this writing, but it is cooperating fully with federal and state health authorities. The company has committed to providing updates as new information becomes available.
Motherly will update this article as more information is released.
